Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Uran Boom: Die Bullen starten durch - spektakuläre Kursgewinne möglich
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
29 Leser
Artikel bewerten:
(0)

Two Day Clinical Trial Regulatory Guideline Requirements Course - London, UK - June 9 - 10, 2016 - Research and Markets

DUBLIN, June 8, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Clinical Trial Regulatory Guideline Requirements (London, UK - June 9 - 10, 2016)" conference to their offering.

Are you up to date with the regulatory requirements for clinical research in Europe? Do you understand the impact of the new EU Clinical Trials Regulation?

The EU Clinical Trials Regulation was finalised and published by the Official Journal of the EU in May 2014 and is due to come into force in 2016. This new regulation will replace the European Clinical Trials Directirs (2001/20/EC). This course will provide an essential understanding to help with compliance for clinical trials, particularly carried out in the EU.

This course will take you through the key regulatory and guideline requirements for clinical research in Europe, including the new Clinical Trial Regulation and existing Directive requirements. Also the key US requirements which impact on trials being carried out in Europe will also be briefly covered.

Why you should attend

Attending this course will help ensure you are familiar with the regulations for running clinical trials and with the recent developments. The course will highlight the most important of these key requirements and changes and how these are likely to impact on trials now and in the future for pharmaceutical, biotechnology companies and study sites.

The course will include a number of group discussions and opportunities for you to discuss issues relevant to your own trials. To maximise the discussions you will be provided with copies of the key guidelines and the new EU Clinical Trial Regulation to review.

This course provides an overview and refresher of the current clinical trail regulatory requirements and an update on the New Clinical Trial Regulation.

For more information visit http://www.researchandmarkets.com/research/qn9wn3/clinical_trial

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.